© Copyright 2025 American Medical Association. All rights reserved.
CPT® Code 46937 refers to the procedure of cryosurgery specifically for the treatment of benign rectal tumors. Cryosurgery is a minimally invasive technique that utilizes extreme cold to destroy or reduce the size of abnormal tissue. In this procedure, the physician employs liquid nitrogen, which is a cryogenic agent, to freeze the tumor. This freezing process effectively targets the tumor cells while preserving the surrounding healthy tissue, thereby minimizing collateral damage. The application of a cryoprobe, which can be either placed directly on the tumor's surface or inserted into the tumor itself, allows for precise delivery of the freezing agent. As the liquid nitrogen circulates through the probe, it super cools the tip, creating an ice ball that engulfs the tumor. The physician monitors the temperature of the tissue to ensure it reaches the necessary level for effective treatment. Once the desired freezing effect is achieved, the probe is deactivated, and the tissue is allowed to thaw. It is important to note that multiple freeze-thaw cycles may be necessary to ensure complete destruction or significant reduction of the tumor. This procedure is specifically coded as 46937 for benign tumors, while a different code, 46938, is designated for malignant tumors.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure of cryosurgery for rectal tumors is indicated for specific conditions that warrant intervention. The following are the explicitly provided indications for performing this procedure:
The cryosurgery procedure for benign rectal tumors involves several critical steps to ensure effective treatment. The following procedural steps outline the process:
After the cryosurgery procedure, the patient may be monitored for a short period to assess any immediate reactions or complications. Post-procedure care typically includes instructions for managing any discomfort or pain, which may be minimal due to the targeted nature of the treatment. The physician may recommend follow-up appointments to evaluate the effectiveness of the procedure and to monitor for any recurrence of the tumor. Patients are advised to report any unusual symptoms or complications that may arise during the recovery period.
Short Descr | CRYOTHERAPY OF RECTAL LESION | Medium Descr | CRYOTHERAPY OF RECTAL LESION | Long Descr | CRYOSURG RCT TUM B9 | APC Status Indicator | Significant Procedure, Multiple Reduction Applies | Type of Service (TOS) | 2 - Surgery | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. | CCS Clinical Classification | 95 - Other non-OR lower GI therapeutic procedures |
Date
|
Action
|
Notes
|
---|---|---|
2010-01-01 | Deleted | - |
Pre-1990 | Added | Code added. |
Get instant expert-level medical coding assistance.